Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-16

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-06-09

    Virtual Booth

    An Enquiry

    Menu

    Stearic Acid

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1ATELVIA

    02 1DICLOFENAC SODIUM

    03 3DOXYCYCLINE HYCLATE

    04 1LIALDA

    05 1MESALAMINE

    06 2PANTOPRAZOLE SODIUM

    07 1RABEPRAZOLE SODIUM

    08 1RISEDRONATE SODIUM

    09 1YOSPRALA

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    ACTAVIS ELIZABETH

    DICLOFENAC SODIUM

    arrow
    DIA 2025
    Not Confirmed
    ACTAVIS ELIZABETH
    Ireland
    arrow
    DIA 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DICLOFENAC SODIUM

    Drug : DICLOFENAC SODIUM

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 74514

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    APIL

    RISEDRONATE SODIUM

    arrow
    DIA 2025
    Not Confirmed
    APIL
    Country
    arrow
    DIA 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RISEDRONATE SODIUM

    Drug : ATELVIA

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 22560

    Country : US

    Patented : Yes

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    AUROBINDO PHARMA USA

    DOXYCYCLINE HYCLATE

    arrow
    DIA 2025
    Not Confirmed
    AUROBINDO PHARMA USA
    India
    arrow
    DIA 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DOXYCYCLINE HYCLATE

    Drug : DOXYCYCLINE HYCLATE

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 91052

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    HERITAGE

    DOXYCYCLINE HYCLATE

    arrow
    DIA 2025
    Not Confirmed
    HERITAGE
    U.S.A
    arrow
    DIA 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DOXYCYCLINE HYCLATE

    Drug : DOXYCYCLINE HYCLATE

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 200856

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    RISING

    DOXYCYCLINE HYCLATE

    arrow
    DIA 2025
    Not Confirmed
    RISING
    U.S.A
    arrow
    DIA 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DOXYCYCLINE HYCLATE

    Drug : DOXYCYCLINE HYCLATE

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 90431

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    TAKEDA PHARMS USA

    MESALAMINE

    arrow
    DIA 2025
    Not Confirmed
    TAKEDA PHARMS USA
    Japan
    arrow
    DIA 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MESALAMINE

    Drug : LIALDA

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 22000

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    TEVA PHARMS USA

    RISEDRONATE SODIUM

    arrow
    DIA 2025
    Not Confirmed
    TEVA PHARMS USA
    Israel
    arrow
    DIA 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RISEDRONATE SODIUM

    Drug : RISEDRONATE SODIUM

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 203217

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    TEVA

    PANTOPRAZOLE SODIUM

    arrow
    DIA 2025
    Not Confirmed
    TEVA
    Israel
    arrow
    DIA 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PANTOPRAZOLE SODIUM

    Drug : PANTOPRAZOLE SODIUM

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 77056

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    TEVA PHARMS USA

    RABEPRAZOLE SODIUM

    arrow
    DIA 2025
    Not Confirmed
    TEVA PHARMS USA
    Israel
    arrow
    DIA 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RABEPRAZOLE SODIUM

    Drug : RABEPRAZOLE SODIUM

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 76822

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    MYLAN

    MESALAMINE

    arrow
    APS Symposium
    Not Confirmed
    MYLAN
    U.S.A
    arrow
    APS Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MESALAMINE

    Drug : MESALAMINE

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 203574

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF